Takanobu Morishita

Toyoake, 4701192, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Advances in treatment of chronic graft-versus-host disease.

Advances in treatment of chronic graft-versus-host disease.

Journal: International journal of hematology
Published: September 19, 2025

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Journal: Frontiers in oncology
Published: August 17, 2025

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Journal: Annals of hematology
Published: July 01, 2025

Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease.

Treatment Response in Individual Organs Affected by Chronic Graft-Versus-Host Disease.

Journal: Cells
Published: December 05, 2024

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.

Journal: International journal of hematology
Published: November 18, 2024

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.

Journal: Journal of hematology
Published: May 26, 2024

Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes.

Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes.

Journal: Cancer science
Published: August 15, 2023

Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.

Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.

Journal: International journal of hematology
Published: March 17, 2023

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.

Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.

Journal: EJHaem
Published: January 04, 2023

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Journal: Cancer science
Published: August 12, 2022

Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.

Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.

Journal: International journal of molecular sciences
Published: March 15, 2022

Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors.

Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors.

Journal: International journal of hematology
Published: April 22, 2021
Showing 1-12 of 41

Last Updated: 09/26/2026